Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Dec 28:4:12.
doi: 10.1186/1742-4755-4-12.

A three-arm randomised controlled trial comparing Gonadotrophin Releasing Hormone (GnRH) agonist long regimen versus GnRH agonist short regimen versus GnRH antagonist regimen in women with a history of poor ovarian response undergoing in vitro fertilisation (IVF) treatment: Poor responders intervention trial (PRINT)

Sesh K Sunkara  1 , Arri Coomarasamy, Yakoub Khalaf, Peter Braude
Affiliations

A three-arm randomised controlled trial comparing Gonadotrophin Releasing Hormone (GnRH) agonist long regimen versus GnRH agonist short regimen versus GnRH antagonist regimen in women with a history of poor ovarian response undergoing in vitro fertilisation (IVF) treatment: Poor responders intervention trial (PRINT)

Sesh K Sunkara et al. Reprod Health. .

Abstract

Background: Poor response to ovarian stimulation with exogenous gonadotrophins occurs in 9-24% of women undergoing in vitro fertilisation (IVF) treatment, which represents an estimated 4000-10,000 women per year in the UK. Poor responders often have their treatment cycle cancelled because of expected poor outcome.One treatment strategy that may influence outcome is the choice of pituitary suppression regimen prior to the initiation of ovarian stimulation. The three commonly used pituitary suppression regimens in IVF treatment are:(1) the GnRH agonist long regimen,(2) the GnRH agonist short regimen and(3) the GnRH antagonist regimen.A systematic review of randomised controlled trials of these pituitary suppression regimens has shown the evidence to be either inconclusive or inconsistent. We therefore designed a three arm randomised trial to evaluate the effectiveness of these regimens in women who had poor ovarian response in a previous IVF treatment cycle.

Methods/design: Consenting, eligible women will be randomised to one of the three regimens using an internet-based trial management programme that ensures allocation concealment and employs block randomisation and minimisation for prognostic variables. The primary outcome is the number of oocytes retrieved. Other outcomes include total dose of follicle stimulating hormone (FSH) used for ovarian stimulation, mature oocytes retrieved, embryos available for transfer, implantation rate and clinical pregnancy rate.The sample size for this trial has been estimated as 102 participants with 34 participants in each of the three arms. Appropriate interim analysis will be conducted by a Data Monitoring and Ethics Committee (DMEC), and the final analysis will be by intention to treat.

Trial registration: ISRCTN27044628.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Meta-analysis of the number of oocytes retrieved with different pituitary suppression regimens in poor responders.
Figure 2
Figure 2
Participant flow chart through the PRINT trial.
Figure 3
Figure 3
GnRH agonist long regimen.
Figure 4
Figure 4
GnRH agonist short regimen.
Figure 5
Figure 5
GnRH antagonist regimen.
See this image and copyright information in PMC

References

    1. Keay SD, Liversedge NH, Mathur RS, Jenkins JM. Assisted conception following poor ovarian reponse to gonadotrophin stimulation. Br J Obstet Gynaecol. 1997;104:521–527. - PubMed
    1. Mahutte NG, Arici A. Poor responders: does the protocol make a difference? Current Opinion in Obstetrics and Gynaecology. 2002;14:275–281. doi: 10.1097/00001703-200206000-00005. - DOI - PubMed
    1. Lashen H, Ledger W, Lopez-Bernal A, Barlow D. Poor responders to ovulation induction: is proceeding to in-vitro fertlization worthwhile? Human Reproduction. 1999;14:964–969. doi: 10.1093/humrep/14.4.964. - DOI - PubMed
    1. Shanbhag S, Aucott L, Bhattacharya S, Hamilton MA, Mc Tavish AR. Interventions for 'poor responders' to controlled ovarian hyperstimulation (COH) in in-vitro fertilisation (IVF) Cochrane Database of Systematic Reviews. 2007. p. CD004379. DOI:10.1002/14651858.CD004379.pub 2. - PubMed
    1. Akman MA, Erden HF, Tosun SB, Bayazit N, Aksoy E, Bahceci M. Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial. Human Reproduction. 2001;16:868–870. doi: 10.1093/humrep/16.5.868. - DOI - PubMed

LinkOut - more resources